Spelling suggestions: "subject:"hypoxiareoxygenation"" "subject:"hypooxygenation""
1 |
Combination vasoactive medication use in asphyxiated newborn pigletsManouchehri, Namdar Unknown Date
No description available.
|
2 |
Combination vasoactive medication use in asphyxiated newborn pigletsManouchehri, Namdar 11 1900 (has links)
With asphyxia, newborns may suffer cardiogenic shock with myocardial dysfunction and dysregulation of vasomotor tone resulting in multiorgan dysfunction. Vasoactive medications are often administered with limited evidence directing clinicians regarding the use of high-dose monotherapy with dopamine relative to combination treatment with dopamine and a second different agent. We hypothesized that the treatment of hypoxia-reoxygenated newborn piglets with combinations of vasoactive medications would improve systemic and regional hemodynamics. Instrumented newborn piglets were subjected to hypoxia-reoxygenation with subsequent infusion of high-dose dopamine or moderate-dose dopamine and one of epinephrine, milrinone or levosimendan. Treatment with high-dose dopamine improved systemic and mesenteric perfusion. The addition of low-dose epinephrine showed some benefits regarding pulmonary hypertension and should a non-catecholamine agent be added to dopamine, milrinone is preferred to levosimendan given benefits to mesenteric perfusion. We conclude that the selection of appropriate vasoactive medical therapy should be directed by the clinical effects desired. / Experimental Surgery
|
3 |
Placental Oxidative Stress in PreeclampsiaVanderlelie, Jessica, n/a January 2006 (has links)
Affecting 6-8% of all pregnancies, preeclampsia is the leading cause of maternal morbidity in the western world and is charactensed by hypertension, proteinuria, edema and platelet aggregation. Despite its prevalence and severity, no comprehensive theory or single factor has been suggested to explain the pathophysiology of this multi system disorder of pregnancy, with the only therapies being bed rest, pharmacological symptom management and if necessary early delivery. Oxidative stress plays an important role in the pathophysiology of preeclampsia, resulting from defective trophoblast invasion, reductions in placental perfusion and placental hypoxia/reoxygenation. The inability of endogenous antioxidant systems up regulated in normal pregnancy, to control increased levels of oxidative stress, is suggested as a possible factor in the feed forward generation of reactive oxygen species and placental oxidative stress. That in turn may stimulate increased syncytiotrophoblast apoptosis, endothelial cell activation and the maternal hyper immune response characteristic of preeclampsia. Analysis of the research literature revealed that previous evaluations of placental oxidation and antioxidant enzyme activity in preeclampsia were by no means comprehensive, and exhibited significant inter-study variations. It was the aim of this thesis to clarify the placental oxidative state and the endogenous antioxidant activity of glutathione peroxidase, thioredoxin reductase, thioredoxin and superoxide dismutase in human placentae in an attempt to determine if variations in antioxidant function were due to changes in gene expression or protein oxidation. The findings reported in this thesis indicate the presence of increased levels of oxidative stress in the preeclamptic placenta, associated with significant reductions in antioxidant enzyme capacity. Quantitative real-time PCR analysis of placental samples revealed that deceases in antioxidant capacity in the placenta are more likely to be related to the significant oxidative burden within the tissue rather than reductions in gene expression. A number of animal models exist to investigate components of preeclampsia pathophysiology, however the ability of these models to mimic the oxidative and antioxidant features of preeclampsia remains unclear. The exposure of pregnant rats to N(G)-nitro-L-arginine methyl ester is a widely used model of endothelial cell dysfunction during preeclampsia. It was the aim of this thesis to determine the biochemical characteristics of this model in an attempt to assess its effectiveness in mimicking oxidative changes in the preeclamptic placenta. Although this model is capable of producing a syndiome in rats similar to the disorder in terms of physiology, this is not manifest in terms of placental biochemistry. The importance of selenium in the synthesis of selenobased antioxidants such as glutathione peroxidase and thioredoxin reductase is well documented. Increasing demand for selenium by the developing fetus may be linked to reductions in selenium status during pregnancy. Considering preeclampsia is associated with significant reductions in selenium status it may be hypothesised that reductions in antioxidant function may be linked to selenium inadequacy. The modulation of dietary selenium in pregnant rats was used to determine the importance of selenium during pregnancy and its effect on antioxidant function and placental oxidative stress. The results of this analysis revealed that selenium deficiency causes a pregnancy specific condition similar to preeclampsia. This condition was found to be associated with increased placental oxidative stress and significant reductions in the systemic activity of selenobased antioxidants that could be modified through selenium supplementation. In summary, data obtained in this thesis indicate that placental oxidative stress and reduced antioxidant enzyme activity play a significant role in the pathogenesis of preeclampsia. These studies support the hypothesis that antioxidant sufficiency is crucial in the maintenance of oxidative balance and that antioxidant dysfunction may result in damage to the placenta and the progression of the disease. These novel data further our understanding of the pathophysiology of preeclampsia and provide new insight into the pathogenesis of clinical complications exhibited in this condition, suggesting antioxidant therapy as a possible means for improving the health outcomes of both mother and baby.
|
4 |
Critical Roles of microRNA-141-3p and CHD8 in Hypoxia/Reoxygenation-Induced Cardiomyocyte ApoptosisYao, Bifeng, Wan, Xiaoya, Zheng, Xinbin, Zhong, Ting, Hu, Jia, Zhou, Yu, Qin, Anna, Ma, Yeshuo, Yin, Deling 21 February 2020 (has links)
Background: Cardiovascular diseases are currently the leading cause of death in humans. The high mortality of cardiac diseases is associated with myocardial ischemia and reperfusion (I/R). Recent studies have reported that microRNAs (miRNAs) play important roles in cell apoptosis. However, it is not known yet whether miR-141-3p contributes to the regulation of cardiomyocyte apoptosis. It has been well established that in vitro hypoxia/reoxygenation (H/R) model can follow in vivo myocardial I/R injury. This study aimed to investigate the effects of miR-141-3p and CHD8 on cardiomyocyte apoptosis following H/R. Results: We found that H/R remarkably reduces the expression of miR-141-3p but enhances CHD8 expression both in mRNA and protein in H9c2 cardiomyocytes. We also found either overexpression of miR-141-3p by transfection of miR-141-3p mimics or inhibition of CHD8 by transfection of small interfering RNA (siRNA) significantly decrease cardiomyocyte apoptosis induced by H/R. Moreover, miR-141-3p interacts with CHD8. Furthermore, miR-141-3p and CHD8 reduce the expression of p21. Conclusion: MiR-141-3p and CHD8 play critical roles in cardiomyocyte apoptosis induced by H/R. These studies suggest that miR-141-3p and CHD8 mediated cardiomyocyte apoptosis may offer a novel therapeutic strategy against myocardial I/R injury-induced cardiovascular diseases.
|
5 |
SR-A Deficiency Reduces Myocardial Ischemia/Reperfusion Injury; Involvement of Increased microRNA-125b Expression in MacrophagesRen, Danyang, Wang, Xiaohui, Ha, Tuanzhu, Liu, Li, Kalbfleisch, John, Gao, Xiang, Williams, David, Li, Chuanfu 01 February 2013 (has links)
The macrophage scavenger receptor class A (SR-A) participates in the innate immune and inflammatory responses. This study examined the role of macrophage SR-A in myocardial ischemia/reperfusion (I/R) injury and hypoxia/reoxygenation (H/R)-induced cell damage. SR-A-/- and WT mice were subjected to ischemia (45min) followed by reperfusion for up to 7days. SR-A-/- mice showed smaller myocardial infarct size and better cardiac function than did WT I/R mice. SR-A deficiency attenuated I/R-induced myocardial apoptosis by preventing p53-mediated Bak-1 apoptotic signaling. The levels of microRNA-125b in SR-A-/- heart were significantly greater than in WT myocardium. SR-A is predominantly expressed on macrophages. To investigate the role of SR-A macrophages in H/R-induced injury, we isolated peritoneal macrophages from SR-A deficient (SR-A-/-) and wild type (WT) mice. Macrophages were subjected to hypoxia followed by reoxygenation. H/R markedly increased NF-κB binding activity as well as KC and MCP-1 production in WT macrophages but not in SR-A-/- macrophages. H/R induced caspase-3/7 and -8 activities and cell death in WT macrophages, but not in SR-A-/- macrophages. The levels of miR-125b in SR-A-/- macrophages were significantly higher than in WT macrophages. Transfection of WT macrophages with miR-125b mimics attenuated H/R-induced caspase-3/7 and -8 activities and H/R-decreased viability, and prevented H/R-increased p-53, Bak-1 and Bax expression. The data suggest that SR-A deficiency attenuates myocardial I/R injury by targeting p53-mediated apoptotic signaling. SR-A-/- macrophages contain high levels of miR-125b which may play a role in the protective effect of SR-A deficiency on myocardial I/R injury and H/R-induced cell damage.
|
6 |
SR-A Deficiency Reduces Myocardial Ischemia/Reperfusion Injury; Involvement of Increased microRNA-125b Expression in MacrophagesRen, Danyang, Wang, Xiaohui, Ha, Tuanzhu, Liu, Li, Kalbfleisch, John, Gao, Xiang, Williams, David, Li, Chuanfu 01 February 2013 (has links)
The macrophage scavenger receptor class A (SR-A) participates in the innate immune and inflammatory responses. This study examined the role of macrophage SR-A in myocardial ischemia/reperfusion (I/R) injury and hypoxia/reoxygenation (H/R)-induced cell damage. SR-A-/- and WT mice were subjected to ischemia (45min) followed by reperfusion for up to 7days. SR-A-/- mice showed smaller myocardial infarct size and better cardiac function than did WT I/R mice. SR-A deficiency attenuated I/R-induced myocardial apoptosis by preventing p53-mediated Bak-1 apoptotic signaling. The levels of microRNA-125b in SR-A-/- heart were significantly greater than in WT myocardium. SR-A is predominantly expressed on macrophages. To investigate the role of SR-A macrophages in H/R-induced injury, we isolated peritoneal macrophages from SR-A deficient (SR-A-/-) and wild type (WT) mice. Macrophages were subjected to hypoxia followed by reoxygenation. H/R markedly increased NF-κB binding activity as well as KC and MCP-1 production in WT macrophages but not in SR-A-/- macrophages. H/R induced caspase-3/7 and -8 activities and cell death in WT macrophages, but not in SR-A-/- macrophages. The levels of miR-125b in SR-A-/- macrophages were significantly higher than in WT macrophages. Transfection of WT macrophages with miR-125b mimics attenuated H/R-induced caspase-3/7 and -8 activities and H/R-decreased viability, and prevented H/R-increased p-53, Bak-1 and Bax expression. The data suggest that SR-A deficiency attenuates myocardial I/R injury by targeting p53-mediated apoptotic signaling. SR-A-/- macrophages contain high levels of miR-125b which may play a role in the protective effect of SR-A deficiency on myocardial I/R injury and H/R-induced cell damage.
|
7 |
Effekte von Hypoxie und Reoxygenierung auf die kontraktile Funktion von Vorhoftrabekeln und Rattenpapillarmuskeln - Möglichkeiten der ProtektionWagner, Kay-Dietrich 01 April 1998 (has links)
Die vorliegende Untersuchung sollte die kontraktile Funktion von humanen Vorhoftrabekeln und linksventrikulären Papillarmuskeln der Ratte während Hypoxie / Reoxygenierung als Hauptkomponenten von Ischämie / Reperfusion charakterisieren. Weitere Merkmale der Ischämie wurden durch erhöhte extrazelluläre K+-Konzentration und Azidose simuliert. Einblicke in die zelluläre Ca2+-Regulation ergaben sich aus Aktionspotential-(AP)-messungen, der SR- Ca2+-ATPase-Aktivität und Kraft-Intervall- Beziehungen. Die Rolle des Energiestoffwechsels und der endogenen antioxidativen Kapazität für die kontraktile Funktion von infarktbedingt hypertrophiertem Rattenmyokard während Hypoxie / Reoxygenierung ist durch Messung der Kreatinkinase-(CK)-Aktivität, ihrer Isoenzymverteilung und der Aktivitäten von Superoxiddismutase (SOD) und Glutathionperoxidase (GSH-Px) charakterisiert worden. Der Einsatz der Radikalfänger Histidin und Butylhydroxytoluen während Hypoxie und schneller Reoxygenierung an Rattenpapillarmuskeln sollte zur Protektion gegen den toxischen Effekt unterschiedlicher reaktiver Sauerstoffspezies dienen. In den durchgeführten Experimenten zeigte sich eine geringere Empfindlichkeit des humanen Vorhofmyokards gegenüber reduzierter O2-Versorgung und Reoxygenierung als im Rattenmyokard. Die während simulierter Ischämie im humanen Myokard auftretende Azidose hat einen günstigen Effekt auf die Wiederherstellung der isometrischen Kontraktionskraft nach Reoxygenierung, was jedoch mit einer gestörten Regulation der kontraktilen Funktion verbunden ist. Hypertrophiertes Myokard in der chronischen Phase nach Infarkt zeigt eine verminderte Empfindlichkeit gegenüber Hypoxie / Reoxygenierung, was auf adaptive Veränderungen im Energiestoffwechsel (erhöhte CK-MB und CK-BB Isoenzyme mit kleinerem Km-Wert für Kreatinphosphat), in der endogenen antioxidativen Kapazität (Erhöhung der Aktivitäten von SOD und GSH-Px um 40% bzw. 50%) und in der Regulation der kontraktilen Funktion (verminderte SR Ca2+-ATPase-Aktivität und Isomyosinverschiebung von V1 nach V3) zurückgeführt werden kann. Eine bessere Erholung der kontraktilen Funktion nach Reoxygenierung kann durch schnellen pO2- Wiederanstieg erreicht werden. Der Einsatz von Pharmaka mit verschiedenen Angriffspunkten im Radikalstoffwechsel und besonders deren Kombination während Hypoxie / Reoxygenierung ermöglicht zusätzlich eine verbesserte Kardioprotektion. / This study characterizes the contractile function of human atrial trabeculae and rat left ventricular papillary muscles during hypoxia / reoxygenation as the major components of ischemia / reperfusion. Further characteristics of ischemia were simulated by increased extracellular K+ concentration and acidosis during hypoxia. Insights into the cellular Ca2+ regulation were obtained from action potential recordings, from measurements of sarcoplasmic reticulum (SR) Ca2+ transport, and from force-interval relations. We examined changes in SR calcium transport, creatine kinase (CK) system, the antioxidant enzymes glutathionperoxidase (GSH-Px) and superoxiddismutase (SOD) 6 wks. after infarction (MI) due to coronary ligation in rats. Phenotypic modifications vs. sham operation (SHAM) were related to the contractile response of hypertrophied papillary muscle to hypoxia / reoxygenation. The oxygen radical scavengers histidine and butylhydroxytoluene were applied during hypoxia and rapid reoxygenation to protect the myocardium against oxygen radical damage. Generally, human atrial trabeculae were less sensitive to reduced oxygen supply and reoxygenation when compared to rat papillary muscles. In human atrial trabeculae, isometric peak force development recovered better after simulated ischemia than after hypoxia but the regulation of contractile function was clearly disturbed. In rat papillary muscles, rapid reoxygenation caused a better recovery of contractile function after hypoxia. Application of the oxygen radical scavengers histidine, butylhydroxytoluene, and especially their combination during hypoxia / reoxygenation had additional cardioprotective effects. In MI vs. SHAM we observed under aerobic control conditions: decreses in isometric contraction and relaxation rate, a reduced Vmax-equivalent of sarcomeric shortening, a faster twitch-to- twitch decay of post-rest potentiation (PRC) which correlated closely to the decrease in SR Ca2+ uptake (-25%), a decrease in CK activity (-20%), reduced CK-MI and CK-MM, increased CK-MB and CK-BB, and enhanced activities of SOD (+40%) and GSH-Px (+50%). During hypoxia, an initial increase in peak force (PF) was followed by a slower PF decline in MI vs. SHAM. During reoxygenation, rates of contraction and relaxation recovered better in MI. In SHAM but not MI, twitch-to-twitch decay of PRC was accelerated after reoxygenation vs. aerobic control. The results suggest that adaptive changes in SR Ca2+ handling, CK isoenzymes, and antioxidant enzymes may contribute to higher resistance against reduced O2 supply and reoxygenation in hypertrophy due to MI.
|
8 |
Lésions d'ischémie-reperfusion rénale en transplantation : modélisation par agents des effets de l’oxygénation sur la dynamique cellulaire-tissulaire de l'inflammation et de la fibrose / Ischemia-reperfusion injury in renal transplantation : agent-based modelling of the effects of oxygenation on the cell-tissue dynamics of inflammation and fibrosisAubert, Vivien 17 December 2015 (has links)
En préservation-transplantation rénale, l’ischémie-reperfusion (IR) induit inflammation, fibrose, dysfonction et perte du greffon. Les événements d’IR sont de mieux en mieux identifiés, mais leurs complexité limite prédiction et thérapeutique. A partir d’une analyse bibliographique détaillée, nous proposons un modèle par agents de la réponse rénale aux lésions d’IR au niveau cellulaire/tissulaire, réalisé avec l'outil de modélisation NetLogo.Dans un premier temps, nous développons un modèle dynamique de l’oxygénation du cortex rénal, avec apport et diffusion de l’oxygène (O2), et consommation dépendant de la filtration. Nous adaptons ce modèle à l’état stationnaire pour l’O2, puis nous couplons les niveaux de PO2 à l'état énergétique (ATP) des cellules épithéliales et endothéliales (avec voies aérobie et anaérobie). Le statut de viabilité cellulaire est lié au niveau d'ATP, aboutissant à une représentation semi-phénoménologique de la réparation/survie vs apoptose/nécrose. Enfin, nous explorons le destin cellulaire et tissulaire lors d’IR simulées, avec l’ajout progressif d’éléments clefs de l’inflammation (invasion tissulaire par leucocytes, signaux lésionnels, phagocytose) et de la fibrose (fibroblastes, collagène). L’évolution du modèle vers la résolution de l’inflammation/régénération du tissu ou vers la fibrose tissulaire est observée selon les conditions imposées (durée/intensité, ischémie vs hypoxémie).Cette construction constitue le premier modèle des effets de l’oxygénation sur la dynamique cellulaire-tissulaire de l’inflammation-fibrose rénale en réponse à l’IR. A terme, elle permettra d'aborder clinique et thérapeutique de la conservation-transplantation rénale. / In renal preservation-transplantation, ischemia-reperfusion (IR) causes graft inflammation and fibrosis, dysfunction and loss. Events involved in IR injury grow identified, but their intricacy hampers prediction and therapeutics. Based on a detailed bibliographical analysis, we propose an Agent-Based Model of renal response to IR injury at cell and tissue levels, created with the modeling tool NetLogo.First, we develop and validate a dynamic model of the oxygenation of the renal cortex, featuring blood perfusion, oxygen diffusion, and oxygen consumption (driven by sodium filtered load and transport). We then adapt this model to oxygen steady-state, and PO2 level is coupled to energetic status (ATP) in epithelial and endothelial cells (aerobic and anaerobic pathways). Cell viability is coupled to ATP level, leading to a semi-phenomenological representation of repair/survival versus apoptosis/necrosis. Finally, we explore (and verify) cell and tissue fate during simulated IR sequences, with the gradual addition of key elements of inflammation (leukocytes infiltration, injury signals, phagocytosis) and fibrosis (fibroblasts, collagen). Model evolution toward the resolution of inflammation/tissue regeneration or toward tissue fibrosis is observed along imposed conditions (duration/intensity, ischemia vs hypoxemia). Results are compared to experiments from our laboratory.This construction is the first model of the effects of oxygenation on cell-tissue dynamics during renal inflammation-fibrosis response to IR. Ultimately, it will allow to address clinical and therapeutic aspects of renal transplantation and conservation.
|
9 |
Protection du myocarde ischémique et pore géant mitochondrial : applications pharmacologiques / Ischemic myocardial protection and mitochondrial permeability transition pore : pharmacological applicationsAssaly, Rana 21 September 2011 (has links)
La maladie coronaire d’origine ischémique reste l’une des principales causes de mortalité dans le monde industrialisé.Le traitement de l’ischémie aiguë du myocarde est entré dans une nouvelle ère où la mortalité peut être diminuée de moitié en utilisant des procédures qui permettent un retour rapide du débit sanguin dans la zone ischémique du myocarde: la revascularisation.Cette reperfusion entraîne des complications appelées lésions de la reperfusion qui ont été décrites pour la 1ère fois par Jennings et al., en 1960. Le développement de stratégies cardioprotectrices associées à la reperfusion constitue un besoin majeur en clinique afin d’améliorer la fonction myocardique, de diminuer l'incidence des arythmies, de retarder l'apparition de la mort cardiomyocytaire et de limiter la taille de l’infarctus du myocarde lors de l'ischémie/reperfusion (I/R).La découverte de 2 formes principales de mécanismes cardioprotecteurs endogènes, a encouragé la recherche de nouveaux moyens pharmacologiques capables de protéger le myocarde ischémié/reperfusé et a développé nos connaissances sur les bases moléculaires des lésions et de la survie cellulaire au cours des processus d’I/R.L’étude des mécanismes responsables de l’induction de la mort cellulaire a permis de mettre en évidence le rôle joué par la mitochondrie et l’augmentation de la perméabilité de ses membranes, induite par la formation/ouverture d’un pore au niveau des points de contacts entre les membranes mitochondriales;ce pore a été appelé « pore de transition de la perméabilité mitochondriale » (mPTP).L’inhibition de l’ouverture de ce pore apparaît comme une stratégie privilégiée pour protéger le myocarde.Des études ont montré que les espèces réactives d’oxygène (EROs) jouent un rôle majeur dans les lésions de l’I/R et dans l’ouverture du mPTP.Il existe peu d’informations claires sur le seuil et la période de production (ischémie et/ou reperfusion) des EROs qui conduisent à l’ouverture du mPTP.Nous avons mis au point un modèle cellulaire d’hypoxie/réoxygénation (H/R) afin d’établir une relation causale entre la production d’EROs, l’ouverture du mPTP et la mort cellulaire tout en explorant le rôle de différents types d’EROs.Ce modèle d’H/R nous a permis de mesurer en temps réel et simultanément la production des EROs, l’ouverture du mPTP et la mort cellulaire.Nous avons montré que la production des EROs débute pendant la période d’hypoxie et qu’elle est directement liée à l’augmentation du temps d’hypoxie.Cette production d’EROs à l’hypoxie, plus particulièrement de radicaux hydroxyles et de peroxyde d’hydrogène, a été directement relié, à l’ouverture du mPTP et à la mort cellulaire lors de l’H/R.Nous avons utilisé ce modèle pour étudier le mécanisme d’action de deux stratégies pharmacologiques cardioprotectrices, un nouveau ligand de la protéine translocatrice mitochondriale (TSPO), le TRO 40303, et l’activation de la voie RISK par la morphine. Nous avons ainsi montré que (1) les propriétés cardioprotectrices du TRO40303 sont associées à une inhibition de l’ouverture du mPTP, ce qui n’avait pas pu être démontré au moyen d’expériences réalisées ex vivo et (2) l’activation de la voie RISK par la morphine, qui aboutit à une limitation de la taille d’infarctus associée à une amélioration des fonctions respiratoires mitochondriales, entraîne également une inhibition de l’ouverture du mPTP et un retard de la mort cellulaire des cardiomyocytes isolés soumis à une H/R.La suite de ce travail sera de rechercher si l’inhibition du stress oxydant peut constituer un mécanisme commun aux deux stratégies pharmacologiques cardioprotectrices en utilisant notre modèle d’H/R.Il serait possible d’étendre notre modèle à des animaux génétiquement modifiés pour appréhender les phénomènes impliqués dans cette activité antioxydante.A plus long terme, il sera nécessaire d’approfondir nos connaissances sur la production d’EROs pendant l’I/R en recherchant plus spécifiquement l’origine de cette production. / Ischemic coronary artery disease remains one of the main causes of mortality in the industrialized countries. The treatment of acute myocardial ischemia entered a new era where mortality can be reduced by 50% using revascularization procedures that allow a rapid return of blood flow to the ischemic area. However, this reperfusion leads to complications known as lethal reperfusion induced injury that have been described for the first time by Jennings et al., in 1960. It became crucial to develop cardioprotective strategies in combination with early reperfusion in order to improve myocardial function, to reduce the incidence of arrhythmias, to delay the onset of cardiomyocytes death and to limit the extension of infarct size following reperfusion. The discovery of two major forms of endogenous cardioprotective mechanisms, which consist of the realization of short cycles of ischemia/reperfusion (I/R) prior to a long period of ischemia (ischemic preconditioning) or before reperfusion after the long period of ischemia (Ischemic Postconditioning), encouraged the search for new pharmacological tools to protect the ischemic myocardium to develop our knowledge on the molecular mechanisms of lethal reperfusion injury and cell survival in the I/R process.The study of cell death mechanisms has highlighted the crucial role of the mitochondria and more specifically the increase in mitochondrial membrane permeability following I/R.One reason for increasing permeability is the formation/opening of a pore at mitochondrial membranes contact sites at reperfusion.This pore has been called "the mitochondrial permeability transition pore" (mPTP). Inhibition of this pore opening has been presented as a main strategy to protect the myocardium.Many studies have shown that reactive oxygen species (ROS) play a major role in I/R injury and mPTP opening, but there is very few information to date about the threshold and the period of ROS production (ischemia and/or reperfusion) that lead to mPTP opening.We designed a cellular model of hypoxia/reoxygenation (H/R) to establish a causal relationship between ROS production, mPTP opening and cell death while exploring the role of different types of ROS.This H/R model used freshly isolated adult rat cardiomyocytes and allowed us to measure online and simultaneously ROS production, mPTP opening and cell death. We have demonstrated that ROS production starts during the period of hypoxia and thisproduction is directly linked to the increase in the duration of hypoxia.This ROS production during hypoxia has been, for the first time, directly related to mPTP opening and cell death following H/R.We used this model to study the mechanism of action of two cardioprotective strategies, a new ligand of the mitochondrial translocator protein (TSPO), TRO 40303 and a RISK (Reperfusion Injury Salvage Kinase) pathway activator, morphine. We have shown that (1) the cardioprotective properties of TRO40303 were associated with inhibition of mPTP opening, a mechanism that could not be demonstrated using ex vivo experiments and (2) morphine that provoked infarct size limitation associated with an improvement of mitochondrial respiratory functions through RISK pathway activation, also inhibited mPTP opening and delayed cell death of isolated cardiomyocytes subjected to H/R.Finally, a question comes into sight whether the inhibition of oxidative stress may be a common mechanism to both cardioprotective pharmacological strategies that we have described using our H/R model. To do this, it would be possible to extend our model to genetically modified animals specifically adapted to understand the phenomena involved in antioxidant activity.On long-term, it will be necessary to develop our knowledge on ROS production during I/R by looking for the origin of this production, more precisely the role of the mitochondria and the effect of other reactive species in order to target the treatment and to develop new cardioprotective strategies.
|
Page generated in 0.0917 seconds